About this Event
Join us for an enlightening event at our site in Guildford, dedicated to understanding migraines, hosted by Re:Cognition Health, global leaders in cognitive research. This event is designed to inform and empower the public by shedding light on the causes of migraines, the latest advances in migraine research, and how clinical trials are shaping the future of treatment.
Exciting breakthroughs in migraine treatment, including new interventions like Atogepant, CGRP monoclonal antibodies, and neuromodulation devices, are changing the landscape of care. Our experts will discuss the ways to access these innovative treatments both through the clinical trial and private pathways.
There will be general information on clinical trials, the processes involved, and how to potentially be involved.
Learn from our clinicians, as they discuss what we already know about migraines, share the latest findings, and explore the clinical trials that are currently available in the UK. Whether you are supporting a loved one with migraines, have been experiencing migraines yourself, or simply want to stay informed, this event is a valuable opportunity to gain insights and take action for your future.
This is more than just an opportunity to learn — it's a chance to be part of something bigger and actively participate in shaping the future of migraines, for yourself and others.
Spaces are limited, so make sure to sign up early to not miss out! Reserve your spot today and join the conversation.
Event Venue & Nearby Stays
Re:Cognition Health, 29 Frederick Sanger Road, Guildford, United Kingdom
GBP 0.00
